Daily non-political popular news in brief.

Synthetic peptide targets latent papilloma virus infections

01-02-2007 · EurekAlert!

Infection with the human papilloma virus, the major cause of cervical cancer, is forever. The virus remains latent in skin cells, ready to flare up at any time to create warts on the skin or the genitals. A new finding by UC Berkeley's Michael Botchan and colleagues offers hope that a drug can halt spread of the virus into new cells, and perhaps even eliminate the virus from the body.

Keywords: synthetic, peptide, targets, latent, papilloma, virus, infections, target, viru, infection

« Previous | Next »

Similar news on "Synthetic peptide targets latent papilloma virus infections":

Tips from the Journals of the American Society for Microbiology
12-12-2006 · EurekAlert!
Featured articles in the upcoming issue of the Journals of the American Society for Microbiology include: "New Test May Allow for Rapid Detection of the Smallpox Virus"; "Novel Peptide Targets Viral Cells and May Inhibit Influenza Virus Infection"; and "Microneedle Vaccination Technique Protects Rabbits Against Inhalation Anthrax Using Smaller Dosage."
Similar news · Read more »
Risk of lymphoma increases with hepatitis C virus infection
05-08-2007 · EurekAlert!
People infected with the hepatitis C virus are at an increased risk of developing certain lymphomas -- cancers of the lymphatic system. Researchers found that HCV infection increased the risk of developing non-Hodgkin's lymphoma by 20 percent to 30 percent. The risk of developing Waldenström's macroglobulinemia -- a rare type of non-Hodgkin's lymphoma -- went up by 300 percent and the risk for cryoglobulinemia, a form of blood vessel inflammation, was also elevated for those with HCV infections.
Similar news · Read more »
Immune cells fighting chronic infections become progressively 'exhausted,' ineffective
10-18-2007 · EurekAlert!
A new study of immune cells battling a chronic viral infection shows that the cells, called T cells, become exhausted by the fight in specific ways, undergoing profound changes that make them progressively less effective over time. The findings also point to interventions that would reverse the changes, suggesting that novel therapies could be developed to reinvigorate T cells that become depleted in their struggle against a virus.
Similar news · Read more »
Blood-brain barrier breached by new therapeutic strategy
06-17-2007 · EurekAlert!
A major obstacle in the treatment of infections and other diseases of the brain is the blood-brain barrier, which prevents systemically delivered therapeutic drugs from reaching the brain. Grantees of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, have now shown that a short protein (peptide) from the rabies virus can carry a strip of therapeutic material into the brain via intravenous administration.
Similar news · Read more »
Major Advance In The Fight Against Chronic Virus Infections
10-11-2006 · ScienceDaily
A major finding that could lead to a new approach for treating hepatitis C and other chronic virus infections was announced today by researchers at the La Jolla Institute for Allergy and Immunology. The research team, using controlled laboratory studies of mice, was able to eliminate a chronic virus infection in the animals by blocking a key messenger molecule in the immune system. The finding has particular relevance for hepatitis C, but may also be applicable to AIDS, cytomegalovirus and other chronic virus infections.
Similar news · Read more »
Depression, aging, and proteins made by a virus may all play role in heart disease
10-01-2007 · EurekAlert!
Researchers here have linked an increase in two immune system proteins essential for inflammation to a latent viral infection and proposed a chain of events that might accelerate cardiovascular disease. The same process may be involved in a host of other ailments plaguing the elderly.
Similar news · Read more »
Humans MIFfed by West Nile Virus
10-01-2007 · EurekAlert!
Infection with West Nile Virus can cause lethal encephalitis and there are currently no vaccines or specific therapeutics for use in humans. However, a new study published in the Journal of Clinical Investigation has provided evidence that the proinflammatory soluble factor MIF might provide a target for developing therapeutics to treat WNV encephalitis.
Similar news · Read more »
First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
07-19-2007 · EurekAlert!
The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology, has yielded a new understanding of why some people can suppress virus levels following HIV infection. "The clearer picture of host responses to the virus achieved through this examination of genomes could lead to improved HIV therapies and provides new targets for vaccine developers," says Elias A. Zerhouni, M.D., director of the National Institutes of Health.
Similar news · Read more »
Should schoolgirls be vaccinated against cancer virus?
10-02-2007 · EurekAlert!
The routine vaccination of children against human papilloma virus -- the first adolescent vaccine against a sexually transmitted infection -- will be discussed at the National Cancer Research Institute conference in Birmingham today Tuesday Oct. 2.
Similar news · Read more »
Recently discovered virus associated with pediatric respiratory tract infection in Germany
11-20-2007 · EurekAlert!
Using a rapid, sensitive, and inexpensive diagnostic tool called MassTag PCR, scientists at Columbia University Mailman School of Public Health's Center for Infection and Immunity implicated a new human rhinovirus as the cause of severe pediatric respiratory tract infections in Europe.
Similar news · Read more »